These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice. Dobarro M; Gerenu G; Ramírez MJ Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694 [TBL] [Abstract][Full Text] [Related]
24. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice. Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430 [TBL] [Abstract][Full Text] [Related]
25. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection. Rametti A; Esclaire F; Yardin C; Cogné N; Terro F Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787 [TBL] [Abstract][Full Text] [Related]
27. Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease. Lloret A; Badia MC; Giraldo E; Ermak G; Alonso MD; Pallardó FV; Davies KJ; Viña J J Alzheimers Dis; 2011; 27(4):701-9. PubMed ID: 21876249 [TBL] [Abstract][Full Text] [Related]
28. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice. Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles. Qin X; Wang Y; Paudel HK Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077 [TBL] [Abstract][Full Text] [Related]
31. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556 [TBL] [Abstract][Full Text] [Related]
32. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease. Zhu Y; Wang J Neurol Sci; 2015 Jul; 36(7):1181-8. PubMed ID: 25596147 [TBL] [Abstract][Full Text] [Related]
33. Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway. Deng J; Habib A; Obregon DF; Barger SW; Giunta B; Wang YJ; Hou H; Sawmiller D; Tan J J Neurochem; 2015 Nov; 135(3):630-7. PubMed ID: 26342176 [TBL] [Abstract][Full Text] [Related]
34. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice. Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570 [TBL] [Abstract][Full Text] [Related]
35. Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β. Vossel KA; Xu JC; Fomenko V; Miyamoto T; Suberbielle E; Knox JA; Ho K; Kim DH; Yu GQ; Mucke L J Cell Biol; 2015 May; 209(3):419-33. PubMed ID: 25963821 [TBL] [Abstract][Full Text] [Related]
36. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity. Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433 [TBL] [Abstract][Full Text] [Related]
37. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737 [TBL] [Abstract][Full Text] [Related]
38. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice. Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765 [TBL] [Abstract][Full Text] [Related]
39. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease. Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103 [TBL] [Abstract][Full Text] [Related]
40. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease. Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]